These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12224523)

  • 21. Induction of protective immunity against lethal anthrax challenge with a patch.
    Kenney RT; Yu J; Guebre-Xabier M; Frech SA; Lambert A; Heller BA; Ellingsworth LR; Eyles JE; Williamson ED; Glenn GM
    J Infect Dis; 2004 Aug; 190(4):774-82. PubMed ID: 15272406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
    Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
    Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the human immune response to the UK anthrax vaccine.
    Baillie L; Townend T; Walker N; Eriksson U; Williamson D
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):267-70. PubMed ID: 15364114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH
    PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.
    Hahn UK; Alex M; Czerny CP; Böhm R; Beyer W
    Int J Med Microbiol; 2004 Jul; 294(1):35-44. PubMed ID: 15293452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of the components of the S-layer in immunogenicity of Bacillus anthracis].
    Mikshis NI; Korsakova AIu; Bolotnikova MF; Novikova LV; Popov IuA
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (1):29-32. PubMed ID: 16532637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation of peptides from Bacillus anthracis protective antigen on Tobacco Mosaic Virus as an epitope targeted anthrax vaccine.
    McComb RC; Ho CL; Bradley KA; Grill LK; Martchenko M
    Vaccine; 2015 Nov; 33(48):6745-51. PubMed ID: 26514421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities.
    Sloat BR; Cui Z
    Pharm Res; 2006 Jun; 23(6):1217-26. PubMed ID: 16718616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
    Yan M; Roehrl MH; Basar E; Wang JY
    Vaccine; 2008 Feb; 26(7):947-55. PubMed ID: 18192092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge.
    Garmory HS; Titball RW; Griffin KF; Hahn U; Böhm R; Beyer W
    Infect Immun; 2003 Jul; 71(7):3831-6. PubMed ID: 12819066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge.
    Lee JS; Hadjipanayis AG; Welkos SL
    Infect Immun; 2003 Mar; 71(3):1491-6. PubMed ID: 12595467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.
    Albrecht MT; Eyles JE; Baillie LW; Keane-Myers AM
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):505-9. PubMed ID: 22515653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthrax vaccination strategies.
    Cybulski RJ; Sanz P; O'Brien AD
    Mol Aspects Med; 2009 Dec; 30(6):490-502. PubMed ID: 19729034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of mucoadhesive carrier adjuvant: toward an oral anthrax vaccine.
    Mangal S; Pawar D; Agrawal U; Jain AK; Vyas SP
    Artif Cells Nanomed Biotechnol; 2014 Feb; 42(1):47-57. PubMed ID: 23452384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I; Gat O; Aloni-Grinstein R; Altboum Z; Inbar I; Kronman C; Bar-Haim E; Cohen S; Velan B; Shafferman A
    Vaccine; 2005 Dec; 23(48-49):5688-97. PubMed ID: 16039760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques.
    Livingston BD; Little SF; Luxembourg A; Ellefsen B; Hannaman D
    Vaccine; 2010 Jan; 28(4):1056-61. PubMed ID: 19896452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rabies virus glycoprotein as a carrier for anthrax protective antigen.
    Smith ME; Koser M; Xiao S; Siler C; McGettigan JP; Calkins C; Pomerantz RJ; Dietzschold B; Schnell MJ
    Virology; 2006 Sep; 353(2):344-56. PubMed ID: 16820183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.